Frovatriptan succinate anhydrousProduct ingredient for Frovatriptan

Name
Frovatriptan succinate anhydrous
Drug Entry
Frovatriptan

Frovatriptan is a triptan drug developed by Vernalis for the treatment of migraine headaches, in particular those associated with menstruation. Frovatriptan causes vasoconstriction of arteries and veins that supply blood to the head.

Accession Number
DBSALT001957
Structure
Synonyms
Not Available
UNII
36K05YF32G
CAS Number
158930-09-7
Weight
Average: 361.398
Monoisotopic: 361.163770853
Chemical Formula
C18H23N3O5
InChI Key
WHTHWNUUXINXHN-SBSPUUFOSA-N
InChI
InChI=1S/C14H17N3O.C4H6O4/c1-16-9-3-5-13-11(7-9)10-6-8(14(15)18)2-4-12(10)17-13;5-3(6)1-2-4(7)8/h2,4,6,9,16-17H,3,5,7H2,1H3,(H2,15,18);1-2H2,(H,5,6)(H,7,8)/t9-;/m1./s1
IUPAC Name
(3R)-3-(methylamino)-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamide; butanedioic acid
SMILES
OC(=O)CCC(O)=O.CN[C@@H]1CCC2=C(C1)C1=C(N2)C=CC(=C1)C(N)=O
ChemSpider
134800
ChEMBL
CHEMBL1200371
Wikipedia
Frovatriptan
Predicted Properties
PropertyValueSource
Water Solubility0.123 mg/mLALOGPS
logP1.2ALOGPS
logP1.08Chemaxon
logS-3.3ALOGPS
pKa (Strongest Acidic)14.54Chemaxon
pKa (Strongest Basic)10.42Chemaxon
Physiological Charge1Chemaxon
Hydrogen Acceptor Count2Chemaxon
Hydrogen Donor Count3Chemaxon
Polar Surface Area70.91 Å2Chemaxon
Rotatable Bond Count5Chemaxon
Refractivity71.84 m3·mol-1Chemaxon
Polarizability27.64 Å3Chemaxon
Number of Rings3Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterYesChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon